Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells

Cancer Chemotherapy and Pharmacology
S GollapudiS Gupta

Abstract

To determine whether probenecid, an inhibitor of organic anion transport, is able to reverse multidrug resistance (MDR) through modulation of the drug transport function of MDR-associated protein (MRP) and P-glycoprotein (P-gP). Two MRP-overexpressing cell lines (HL60/AR and H69/AR) and two P-gP-overexpressing cell lines (HL60/Tax and P388/ADR) were cultured with different concentrations of daunorubicin (DNR) or vincristine (VCR) in the presence or absence of various concentrations of probenecid (0.01-10 mM). Drug sensitivity was determined using an MTT assay. DNR accumulation and subcellular distribution were determined by flow cytometry and confocal microscopy respectively. VCR accumulation was determined by scintillation spectrometry. Probenecid, in a concentration-dependent manner, reversed resistance to DNR and VCR in HL60/AR and H69/AR tumor cell lines. This effect of probenecid on MDR was associated with an increased accumulation of DNR and VCR and correction of the altered subcellular distribution of DNR. The concentrations of probenecid that reversed MDR are clinically achievable in vivo. In contrast, probenecid did not reverse MDR in either HL60/Tax or P388/ADR tumor cell lines that overexpress P-gP. These results sug...Continue Reading

Citations

Aug 24, 2011·Cancer Chemotherapy and Pharmacology·Denise Campos-ArroyoJorge Melendez-Zajgla
Mar 10, 2004·Biochemical Pharmacology·Sharon WeinChristine Coméra
Feb 28, 2002·European Journal of Pharmacology·Nagesh Bandi, Uday B Kompella
Dec 13, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A EnerothK Gjellan
Jul 20, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Andreas LeuschWilly Roth
Jun 7, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hiroshi SaitohKaoru Hosoi
Mar 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Z BenderraM Manfait
Feb 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Jeanette I Webster, Jan Carlstedt-Duke
Jun 29, 2002·Breast Cancer Research and Treatment·David ChauvierMichel Manfait
Sep 21, 2000·British Journal of Haematology·S PoulainP Fenaux
Dec 7, 2007·Antimicrobial Agents and Chemotherapy·Jayati Mookerjee BasuSyamal Roy
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·G J LeitchG S Visvesvara
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Jean-Michel MichotPaul M Tulkens
Dec 19, 2000·Biochemical and Biophysical Research Communications·M Issandou, T Grand-Perret
May 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ralph N WattsDes R Richardson
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Nicole H P CnubbenPeter J van Bladeren
Jan 16, 2003·The Journal of Physiology·Ivan Manzini, Detlev Schild
Jul 13, 2002·Journal of Pharmaceutical Sciences·David ChauvierMichel Manfait
Apr 10, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C JoveletS Gil
Mar 7, 2006·Journal of Veterinary Pharmacology and Therapeutics·J DupuyM Alvinerie
Mar 5, 2016·Journal of Medicinal Chemistry·Sven Marcel SchmittMichael Wiese
Aug 16, 2005·Biochemical and Biophysical Research Communications·Zdena SulováAlbert Breier
Sep 12, 2006·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Viera BohácováAlbert Breier
Jul 12, 2002·Biochemical Pharmacology·Loukas TatidisSigurd Vitols
Dec 14, 1999·Japanese Journal of Cancer Research : Gann·T MinaminoK Miyamoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.